Do self-management interventions in COPD patients work and which patients benefit most? An individual patient data meta-analysis

International Journal of COPD

Volumn 11, Issue 1, 2016, Pages 2063-2074

  Jonkman, Nini H ^a   Westland, Heleen ^a   Trappenburg, Jaap C A ^a   Groenwold, Rolf H H ^a   Bischoff, Erik W M A ^b   Bourbeau, Jean ^c   Bucknall, Christine E ^d   Coultas, David ^e   Effing, Tanja W ^f   Epton, Michael J ^g   Gallefoss, Frode ^h   Garcia Aymerich, Judith ^i,j,k   Lloyd, Suzanne M ^l   Monninkhof, Evelyn M ^a   Nguyen, Huong Q ^m   van der Palen, Job ^n,o   Rice, Kathryn L ^p   Sedeno, Maria ^c   Taylor, Stephanie J C ^q   Troosters, Thierry ^r   Zwar, Nicholas A ^s   Hoes, Arno W ^a   Schuurmans, Marieke J ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f REPATRIATION GENERAL HOSPITAL   (Australia)

^g CHRISTCHURCH HOSPITAL   (New Zealand)

^h Sørlandet Hospital   (Norway)

ⁱ CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^j UNIVERSITAT POMPEU FABRA   (Spain)

^k CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^l UNIVERSITY OF GLASGOW   (United Kingdom)

^m KAISER PERMANENTE   (United States)

ⁿ UNIVERSITY OF TWENTE   (Netherlands)

^o MEDISCH SPECTRUM TWENTE   (Netherlands)

^p UNIVERSITY OF MINNESOTA   (United States)

^q QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^r UNIVERSITY OF LEUVEN   (Belgium)

^s UNIVERSITY OF NEW SOUTH WALES   (Australia)

more..

Author keywords

Chronic obstructive pulmonary disease; Individual patient data meta analysis; Self management; Subgroup analysis

Indexed keywords

ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; HOSPITALIZATION; HUMAN; META ANALYSIS; MORTALITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CARE; SELF CONCEPT; SEX DIFFERENCE; AGED; CONVALESCENCE; DISEASE COURSE; EVIDENCE BASED MEDICINE; FEMALE; FORCED EXPIRATORY VOLUME; LUNG; MALE; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PATIENT SELECTION; PROCEDURES; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AGED; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; LUNG; MALE; MIDDLE AGED; ODDS RATIO; PATIENT SELECTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; RISK FACTORS; SELF CARE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84988689700     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S107884     Document Type: Article

References (48)

1. Mathers C, Boerma T, Ma Fat D. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization; 2008.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. GOLD, 2015. Available from: www.goldcopd.org. Accessed October 26, 2015.
3. Bourbeau J, van der Palen J. Promoting effective self-management programmes to improve COPD. Eur Respir J. 2009;33:461–463.
4. Zwerink M, Brusse-Keizer M, van der Valk PD, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;3:CD002990.
5. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003;163:585–591.
6. Rice KL, Dewan N, Bloomfield HE, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2010;182:890–896.
7. Bucknall CE, Miller G, Lloyd SM, et al. Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial. BMJ. 2012;344:e1060.
8. Bischoff EW, Akkermans R, Bourbeau J, et al. Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. BMJ. 2012;345:e7642.
9. Fan VS, Gaziano JM, Lew R, et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med. 2012;156:673–683.
10. Nici L, Bontly TD, Zuwallack R, Gross N. Self-management in chronic obstructive pulmonary disease. Time for a paradigm shift? Ann Am Thorac Soc. 2014;11:101–107.
11. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.
12. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. The Cochrane Collaboration; 2011.
13. Jonkman NH, Westland H, Trappenburg JC, et al. Towards tailoring of self-management for patients with chronic heart failure or chronic obstructive pulmonary disease: a protocol for an individual patient data meta-analysis. BMJ Open. 2014;4:e005220.
14. McGowan PT. Self-management education and support in chronic disease management. Prim Care. 2012;39:307–325.
15. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–778.
16. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321–1327.
17. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30:473–483.
18. Groothuis-Oudshoorn K, van Buuren S. MICE: Multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1–67.
19. Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials. 2005;2: 209–217.
20. Rubin DB. Multiple Imputation for Non-response in Surveys. New York: John Wiley & Sons; 1987.
21. Khdour MR, Kidney JC, Smyth BM, McElnay JC. Clinical pharmacy-led disease and medicine management programme for patients with COPD. Br J Clin Pharmacol. 2009;68:588–598.
22. Ninot G, Moullec G, Picot MC, et al. Cost-saving effect of supervised exercise associated to COPD self-management education program. Respir Med. 2011;105:377–385.
23. Rea H, McAuley S, Stewart A, et al. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J. 2004;34:608–614.
24. Wakabayashi R, Motegi T, Yamada K, et al. Efficient integrated education for older patients with chronic obstructive pulmonary disease using the Lung Information Needs Questionnaire. Geriatr Gerontol Int. 2011;11:422–430.
25. Watson PB, Town GI, Holbrook N, Dwan C, Toop LJ, Drennan CJ. Evaluation of a self-management plan for chronic obstructive pulmonary disease. Eur Respir J. 1997;10:1267–1271.
26. Wood-Baker R, McGlone S, Venn A, Walters EH. Written action plans in chronic obstructive pulmonary disease increase appropriate treatment for acute exacerbations. Respirology. 2006;11:619–626.
27. Casas A, Troosters T, Garcia-Aymerich J, et al. Integrated care prevents hospitalizations for exacerbations in COPD patients. Eur Respir J. 2006; 28:123–130.
28. Coultas D, Frederick J, Barnett B, Singh G, Wludyka P. A randomized trial of two types of nurse-assisted home care for patients with COPD. Chest. 2005;128:2017–2024.
29. Effing T, Kerstjens H, van der Valk P, Zielhuis G, van der Palen J. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax. 2009; 64:956–962.
30. Gallefoss F, Bakke PS, Kjaersgaard PK. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159: 812–817.
31. McGeoch GR, Willsman KJ, Dowson CA, et al. Self-management plans in the primary care of patients with chronic obstructive pulmonary disease. Respirology. 2006;11:611–618.
32. Monninkhof E, van der Valk P, van der Palen J, van Herwaarden C, Zielhuis G. Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease. Eur Respir J. 2003; 22:815–820.
33. Nguyen HQ, Donesky D, Reinke LF, et al. Internet-based dyspnea self-management support for patients with chronic obstructive pulmonary disease. J Pain Symptom Manage. 2013;46:43–55.
34. Taylor SJC, Sohanpal R, Bremner SA, et al. Self-management support for moderate-to-severe chronic obstructive pulmonary disease: A pilot randomised controlled trial. Br J Gen Pract. 2012;62:e687–e695.
35. Trappenburg JC, Monninkhof EM, Bourbeau J, et al. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax. 2011;66:977–984.
36. Zwar NA, Hermiz O, Comino E, et al. Care of patients with a diagnosis of chronic obstructive pulmonary disease: a cluster randomised controlled trial. Med J Aust. 2012;197:394–398.
37. Majothi S, Jolly K, Heneghan NR, et al. Supported self-management for patients with COPD who have recently been discharged from hospital: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:853–867.
38. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:728–735.
39. Ramachandran K, McCusker C, Connors M, Zuwallack R, Lahiri B. The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chron Respir Dis. 2008;5:205–209.
40. Vagaggini B, Costa F, Antonelli S, et al. Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. Respir Med. 2009;103:1224–1230.
41. Sun X, Ioannidis JPA, Agoritsas T, et al. How to use a subgroup analysis: users’ guide to the medical literature. JAMA. 2014;311:405–411.
42. Tierney JF, Vale C, Riley R, et al. Individual participant data (IPD) meta-analyses of randomised controlled trials: guidance on their use. PLoS Med. 2015;12:e1001855.
43. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363: 1128–1138.
44. Trappenburg JC, van Deventer AC, Troosters T, et al. The impact of using different symptom-based exacerbation algorithms in patients with COPD. Eur Respir J. 2011;37:1260–1268.
45. Bischoff EW, Hamd DH, Sedeno M, et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax. 2011;66:26–31.
46. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P; CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148:295–309.
47. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–586.
48. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16:622–626.